Tamoxifen is recommended for premenopausal and postmenopausal women with ER+ breast cancer. It is also an option for women at high risk of developing breast cancer. Raloxifene is recommended for postmenopausal women who are at high risk for invasive breast cancer and who also need treatment for osteoporosis.
